Novartis Ag NVS
NYSE NVS
$141.01 -0.05 (-0.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Novartis Ag (NVS) posted Return on Invested Capital [ROIC] of 21.95% for Q2 2026, down 4.82 percentage points from 26.77% a year earlier and down 0.77 percentage points from the prior quarter.

Analysis

Novartis Ag (NVS) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2025, Novartis Ag's Return on Invested Capital [ROIC] came in at 24.97%, up 2.93 percentage points from FY2024.

  • Annual Return on Invested Capital [ROIC] has increased for three consecutive years, with a five-year change of +14.64 percentage points (FY2020 to FY2025).
  • In prior years, Novartis Ag's Return on Invested Capital [ROIC] was 22.05% in FY2024 (+8.69 pp), 13.35% in FY2023 (+3.13 pp), 10.22% in FY2022 (-2.44 pp) and 12.66% in FY2021 (+2.32 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Invested Capital [ROIC] since Q4 2024.
  • On a year-over-year basis, Return on Invested Capital [ROIC] increased in six of the last eight quarters, with an average year-over-year change of +3.62 percentage points.
  • The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was Q1 2025, with a gain of 7.94 percentage points; the weakest was Q2 2026, with a drop of 4.82 percentage points.
  • According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was 22.72% (Q1 2026), 24.76% (Q4 2025) and 26.63% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.95%
Mar 31, 2026 22.72%
Dec 31, 2025 24.76%
Sep 30, 2025 26.63%
Jun 30, 2025 26.77%
Mar 31, 2025 25.08%
Dec 31, 2024 21.82%
Sep 30, 2024 21.12%
Jun 30, 2024 19.80%
Mar 31, 2024 17.15%
Dec 31, 2023 16.00%
Sep 30, 2023 14.14%
Jun 30, 2023 12.62%
Mar 31, 2023 11.01%
Dec 31, 2022 10.75%
Sep 30, 2022 11.42%
Jun 30, 2022 12.81%
Mar 31, 2022 15.20%
Dec 31, 2021 15.08%
Sep 30, 2021 14.81%
API Access

Novartis Ag Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NVS&period=max&api_key=YOUR_API_KEY